{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:41:49Z","timestamp":1767991309283,"version":"3.49.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1998,2,1]],"date-time":"1998-02-01T00:00:00Z","timestamp":886291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"vor","delay-in-days":8059,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1998,2]]},"DOI":"10.1023\/a:1008235801218","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T08:47:34Z","timestamp":1040546854000},"page":"221-223","source":"Crossref","is-referenced-by-count":6,"title":["Cytosine arabinoside, etoposide and aclarubicin (AVA) for the treatment of acute myeloid leukemia (AML) in elderly patients"],"prefix":"10.1016","volume":"9","author":[{"given":"P.","family":"Staib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Lathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kn\u00f6ppel-Schwark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Tesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Voliotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.T.","family":"Steinmetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schwonzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.D.","family":"Wickramanayake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008235801218_bb0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/1097-0142(19870715)60:2<149::AID-CNCR2820600204>3.0.CO;2-F","article-title":"Intensive treatment of acute leukemia in adults 70 years of age and older","volume":"60","author":"Walters","year":"1987","journal-title":"Cancer"},{"key":"10.1023\/A:1008235801218_bb0015","series-title":"Acute Leukemias IV","first-page":"513","article-title":"Chemotherapy intensity and long-term outcome in AML","author":"B\u00fcchner","year":"1994"},{"key":"10.1023\/A:1008235801218_bb0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1182\/blood.V79.2.313.313","article-title":"Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia","volume":"79","author":"Wiernik","year":"1992","journal-title":"Blood"},{"key":"10.1023\/A:1008235801218_bb0025","first-page":"9","article-title":"Experimental studies on aclacinomycin","author":"Tone","year":"1985","journal-title":"Drugs Exp Clin Res"},{"key":"10.1023\/A:1008235801218_bb0030","first-page":"510","article-title":"Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: A danish national phase III trial","volume":"5","author":"Hansen","year":"1991","journal-title":"Leukemia"},{"key":"10.1023\/A:1008235801218_bb0035","first-page":"245","article-title":"Difference between the resistance mechanisms of aclacinomycin- and adriamycin-resistant P388 cell lines","volume":"7","author":"Dong","year":"1995","journal-title":"Oncol Res"},{"key":"10.1023\/A:1008235801218_bb0040","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/mpo.2950140604","article-title":"Phase I-II trial of VP-16 in the treatment of acute nonlymphocytic leukemia and blast crisis of chronic granulocytic leukemia","volume":"14","author":"Mailliard","year":"1986","journal-title":"Med Pediatr Oncol"},{"key":"10.1023\/A:1008235801218_bb0045","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJM199410063311402","article-title":"Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B","volume":"331","author":"Mayer","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008235801218_bb0050","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF01695033","article-title":"Results of conventional-dose cytosine arabinoside and idarubicin in elderly patients with acute myeloid leukemia","volume":"68","author":"Heyll","year":"1994","journal-title":"Ann Hematol"},{"key":"10.1023\/A:1008235801218_bb0055","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/10428199409073785","article-title":"Phase II-trial of double-consolidation following intensive induction treatment for improvement of survival in elderly patients with acute myeloid leukemia","volume":"12","author":"Jehn","year":"1994","journal-title":"Leuk Lymph"},{"key":"10.1023\/A:1008235801218_bb0060","first-page":"231","article-title":"De novo acute myeloid leukaemia in patients over 55-years-old: A population-based study of incidence, treatment and outcome","volume":"9","author":"Taylor","year":"1995","journal-title":"Leukemia"},{"key":"10.1023\/A:1008235801218_bb0065","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-2141.1993.tb03170.x","article-title":"Prognostic factors in elderly patients with acute myeloid leukaemia: Development of a model to predict survival","volume":"85","author":"Johnson","year":"1993","journal-title":"Br J Haematol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419553583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419553583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/9\/2\/221\/19481860\/9-2-221.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T12:17:31Z","timestamp":1582633051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419553583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,2]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,2]]}},"alternative-id":["S0923753419553583"],"URL":"https:\/\/doi.org\/10.1023\/a:1008235801218","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1998,2]]}}}